{"id":"https://openalex.org/W2136607120","doi":"https://doi.org/10.3109/10611869608996830","title":"Liposome Longevity and Stability in Circulation: Effects on the in vivo Delivery to Tumors and Therapeutic Efficacy of Encapsulated Anthracyclines","display_name":"Liposome Longevity and Stability in Circulation: Effects on the in vivo Delivery to Tumors and Therapeutic Efficacy of Encapsulated Anthracyclines","alternate_titles":[],"publication_year":1996,"publication_date":"1996-01-01","ids":{"openalex":"https://openalex.org/W2136607120","doi":"https://doi.org/10.3109/10611869608996830","mag":"2136607120","pmid":"https://pubmed.ncbi.nlm.nih.gov/8866658"},"language":"en","primary_location":{"id":"doi:10.3109/10611869608996830","doi":"https://doi.org/10.3109/10611869608996830","is_oa":false,"landing_page_url":"https://doi.org/10.3109/10611869608996830","pdf_url":null,"source":{"id":"https://openalex.org/S100629371","display_name":"Journal of drug targeting","issn_l":"1026-7158","issn":["1026-7158","1029-2330","1061-186X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Drug Targeting","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2136607120"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5060158935","display_name":"Alberto Gabiz\u00f3n","orcid":"https://orcid.org/0000-0003-1332-1164","observed_orcids":["https://orcid.org/0000-0003-1332-1164"]},"institutions":[{"id":"https://openalex.org/I2799899409","display_name":"Hadassah Medical Center","ror":"https://ror.org/01cqmqj90","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799899409"]}],"countries":["IL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A. Gabizon","raw_affiliation_strings":["Sharet Institute of Oncology, Hadassah Hebrew University Medical Center, Jerusalem, Israel","Sharet Institute of Oncology, Hadassah Hebrew University Medical Center, Jerusalem, 91120, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sharet Institute of Oncology, Hadassah Hebrew University Medical Center, Jerusalem, Israel","institution_ids":["https://openalex.org/I2799899409"]},{"raw_affiliation_string":"Sharet Institute of Oncology, Hadassah Hebrew University Medical Center, Jerusalem, 91120, Israel","institution_ids":["https://openalex.org/I2799899409"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040475932","display_name":"Michal Chemla","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799899409","display_name":"Hadassah Medical Center","ror":"https://ror.org/01cqmqj90","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799899409"]}],"countries":["IL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M. Chemla","raw_affiliation_strings":["Sharet Institute of Oncology, Hadassah Hebrew University Medical Center, Jerusalem, 91120, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sharet Institute of Oncology, Hadassah Hebrew University Medical Center, Jerusalem, 91120, Israel","institution_ids":["https://openalex.org/I2799899409"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011898524","display_name":"Dina Tzemach","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799899409","display_name":"Hadassah Medical Center","ror":"https://ror.org/01cqmqj90","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799899409"]}],"countries":["IL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"D. Tzemach","raw_affiliation_strings":["Sharet Institute of Oncology, Hadassah Hebrew University Medical Center, Jerusalem, 91120, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sharet Institute of Oncology, Hadassah Hebrew University Medical Center, Jerusalem, 91120, Israel","institution_ids":["https://openalex.org/I2799899409"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066659326","display_name":"Aviva T. Horowitz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799899409","display_name":"Hadassah Medical Center","ror":"https://ror.org/01cqmqj90","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799899409"]}],"countries":["IL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A. T. Horowitz","raw_affiliation_strings":["Sharet Institute of Oncology, Hadassah Hebrew University Medical Center, Jerusalem, 91120, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sharet Institute of Oncology, Hadassah Hebrew University Medical Center, Jerusalem, 91120, Israel","institution_ids":["https://openalex.org/I2799899409"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5086486880","display_name":"Dorit Goren","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799899409","display_name":"Hadassah Medical Center","ror":"https://ror.org/01cqmqj90","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799899409"]}],"countries":["IL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"D. Goren","raw_affiliation_strings":["Sharet Institute of Oncology, Hadassah Hebrew University Medical Center, Jerusalem, 91120, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sharet Institute of Oncology, Hadassah Hebrew University Medical Center, Jerusalem, 91120, Israel","institution_ids":["https://openalex.org/I2799899409"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I2799899409"],"apc_list":null,"apc_paid":null,"fwci":6.1067,"has_fulltext":false,"cited_by_count":105,"citation_normalized_percentile":{"value":0.97807638,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"3","issue":"5","first_page":"391","last_page":"398"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10958","display_name":"Ultrasound and Hyperthermia Applications","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2204","display_name":"Biomedical Engineering"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/liposome-stability","display_name":"liposome stability","score":0.8149999976158142},{"id":"https://openalex.org/keywords/pegylated-liposomes","display_name":"PEGylated liposomes","score":0.7670000195503235},{"id":"https://openalex.org/keywords/tumor-drug-delivery","display_name":"tumor drug delivery","score":0.7559999823570251},{"id":"https://openalex.org/keywords/phosphatidylglycerol","display_name":"phosphatidylglycerol","score":0.8360000252723694},{"id":"https://openalex.org/keywords/phosphatidylinositol","display_name":"phosphatidylinositol","score":0.9850000143051147},{"id":"https://openalex.org/keywords/surface-charge","display_name":"surface charge","score":0.5809999704360962},{"id":"https://openalex.org/keywords/solid-carcinoma","display_name":"solid carcinoma","score":0.7730000019073486},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.5289999842643738},{"id":"https://openalex.org/keywords/liposomal-chemotherapy","display_name":"liposomal chemotherapy","score":0.42500001192092896}],"concepts":[{"id":"https://openalex.org/C185154212","wikidata":"https://www.wikidata.org/wiki/Q410454","display_name":"Liposome","level":2,"score":0.8798983097076416},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.6494793891906738},{"id":"https://openalex.org/C54400483","wikidata":"https://www.wikidata.org/wiki/Q1793202","display_name":"PEG ratio","level":2,"score":0.6044066548347473},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5787990689277649},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5304654836654663},{"id":"https://openalex.org/C2779820397","wikidata":"https://www.wikidata.org/wiki/Q1392806","display_name":"Drug delivery","level":2,"score":0.5047644376754761},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.48985883593559265},{"id":"https://openalex.org/C2776964284","wikidata":"https://www.wikidata.org/wiki/Q410083","display_name":"Polyethylene glycol","level":2,"score":0.467292845249176},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4280610978603363},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.329402893781662},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.19557401537895203},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.14353153109550476},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C10138342","wikidata":"https://www.wikidata.org/wiki/Q43015","display_name":"Finance","level":1,"score":0.0},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001202","descriptor_name":"Ascitic Fluid","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D001665","descriptor_name":"Binding Sites","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002277","descriptor_name":"Carcinoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D002277","descriptor_name":"Carcinoma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D002286","descriptor_name":"Carcinoma, Ehrlich Tumor","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002286","descriptor_name":"Carcinoma, Ehrlich Tumor","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004339","descriptor_name":"Drug Compounding","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008081","descriptor_name":"Liposomes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D008081","descriptor_name":"Liposomes","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D009374","descriptor_name":"Neoplasms, Experimental","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009374","descriptor_name":"Neoplasms, Experimental","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011092","descriptor_name":"Polyethylene Glycols","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D011092","descriptor_name":"Polyethylene Glycols","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013810","descriptor_name":"Therapeutic Equivalency","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016503","descriptor_name":"Drug Delivery Systems","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018943","descriptor_name":"Anthracyclines","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018943","descriptor_name":"Anthracyclines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018943","descriptor_name":"Anthracyclines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.3109/10611869608996830","doi":"https://doi.org/10.3109/10611869608996830","is_oa":false,"landing_page_url":"https://doi.org/10.3109/10611869608996830","pdf_url":null,"source":{"id":"https://openalex.org/S100629371","display_name":"Journal of drug targeting","issn_l":"1026-7158","issn":["1026-7158","1029-2330","1061-186X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Drug Targeting","raw_type":"journal-article"},{"id":"pmid:8866658","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8866658","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of drug targeting","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":25,"referenced_works":["https://openalex.org/W54487843","https://openalex.org/W1484032922","https://openalex.org/W1485309471","https://openalex.org/W1488571428","https://openalex.org/W1570509890","https://openalex.org/W1574249403","https://openalex.org/W1663301241","https://openalex.org/W1769308960","https://openalex.org/W1902883158","https://openalex.org/W1956382989","https://openalex.org/W1961763055","https://openalex.org/W1964441264","https://openalex.org/W2001107461","https://openalex.org/W2009038500","https://openalex.org/W2012879110","https://openalex.org/W2024564160","https://openalex.org/W2030879715","https://openalex.org/W2036944284","https://openalex.org/W2105085256","https://openalex.org/W2118878458","https://openalex.org/W2153484092","https://openalex.org/W2156246685","https://openalex.org/W2158449037","https://openalex.org/W2169794253","https://openalex.org/W2171127982"],"related_works":["https://openalex.org/W2153484092","https://openalex.org/W2285829642","https://openalex.org/W2191533517","https://openalex.org/W2118878458","https://openalex.org/W1490119519","https://openalex.org/W1996828453","https://openalex.org/W2241364172","https://openalex.org/W2030879715","https://openalex.org/W2323591151","https://openalex.org/W1994183234"],"abstract_inverted_index":{"The":[0,164],"effect":[1],"of":[2,13,68,105,161,178],"liposome":[3,57,182],"composition":[4],"on":[5],"drug":[6,40,130],"delivery":[7],"to":[8,63,156,171],"tumors":[9],"and":[10,28,48,138,180],"therapeutic":[11,69,159,166,176],"efficacy":[12,160],"liposome-encapsulated":[14,162],"anthracyclines":[15],"was":[16,61,132],"investigated":[17],"in":[18,34,42,99,103,113,141,148,188],"two":[19],"murine":[20],"tumor":[21,25,46,52,143],"models:":[22],"an":[23,65],"ascitic":[24],"(J6456":[26],"lymphoma)":[27],"a":[29],"solid":[30],"carcinoma":[31],"(M-109).":[32],"Longevity":[33],"circulation":[35,104,189],"correlated":[36],"positively":[37],"with":[38,49,91,152,184],"high":[39,79],"levels":[41],"the":[43,74,106,118,123,128,158,175],"extracellular":[44],"(ascitic)":[45],"fluid":[47],"delayed":[50],"peak":[51],"levels.":[53],"Using":[54],"polyethylene-glycol(PEG)-coated":[55],"liposomes,":[56],"stability":[58],"(drug":[59],"retention)":[60],"found":[62],"be":[64],"important":[66],"determinant":[67],"efficacy,":[70],"as":[71,150],"indicated":[72],"by":[73,78],"superior":[75],"survival":[76],"conferred":[77],"Tm":[80,86],"phosphatidylcholines":[81],"(hydrogenated,":[82],"dipalmitoyl)":[83],"over":[84],"low":[85],"(egg":[87],"phosphatidyl-choline).":[88],"Replacing":[89],"PEG":[90,124,137,153,179],"another":[92],"negatively-charged":[93],"surface":[94,119],"headgroup":[95,121],"(phosphatidyl-glycerol,":[96],"phosphatidyl-inositol)":[97],"resulted":[98],"relatively":[100,185],"shorter":[101],"longevity":[102,147],"liposome-associated":[107],"drug,":[108],"but":[109],"no":[110],"detectable":[111],"differences":[112,173,187],"anti-tumor":[114],"efficacy.":[115],"When":[116],"neither":[117],"charged":[120],"nor":[122],"coating":[125],"are":[126],"present,":[127],"resulting":[129],"formulation":[131],"significantly":[133],"less":[134],"effective":[135],"than":[136],"phosphatidylinositol-based":[139],"formulations":[140,183],"both":[142],"models.":[144],"In":[145],"conclusion,":[146],"circulation,":[149],"obtained":[151],"coating,":[154],"tends":[155],"improve":[157],"anthracyclines.":[163],"current":[165],"models":[167],"were":[168],"however":[169],"unable":[170],"detect":[172],"between":[174],"activity":[177],"other":[181],"small":[186],"longevity.":[190]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2136607120","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
